.png)
Soluble Guanylate Cyclase Market by Type and Application - Global Industry Analysis & Forecast to 2027
Published On : December 2019 Pages : 142 Category: Pharma & Healthcare Report Code : HC127791
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Soluble Guanylate Cyclase Market by Type (BAY-1636183, Hydroxyurea, BI-703704, IW-1701) Application (Cardiovascular, Metabolic Disorders, Ophthalmology, Gastrointestinal) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Soluble Guanylate Cyclase Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Solvent guanylyl cyclase is the main known receptor for nitric oxide, NO. It is dissolvable, for example totally intracellular. Most eminently, this chemical is associated with vasodilation. In people, it is encoded by the qualities GUCY1A3, GUCY1A2, GUCY1B3 and GUCY1B2. It is ordered under EC number 4.6.1.2. sGC is a heterodimer made out of one alpha (1, 2) and one heme-restricting beta (1, 2) subunits. Every subunit comprises of four spaces: a PAS-like domain, a C-terminal catalytic domain, an N-terminal HNOX domain and a coiled-col domain.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- NicOx SA
- Ironwood Pharmaceuticals Inc
- SynZyme Technologies LLC
- Boehringer Ingelheim GmbH
- Topadur Pharma AG
- Bayer AG
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Soluble Guanylate Cyclase Market , By Type, Estimates and Forecast, 2017-2027 ($Million)
o BAY-1636183
o Hydroxyurea
o BI-703704
o IW-1701
· Soluble Guanylate Cyclase Market , By Application, Estimates and Forecast, 2017-2027 ($Million)
o Cardiovascular
o Metabolic Disorders
o Ophthalmology
o Gastrointestinal
· Soluble Guanylate Cyclase Market , By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o NicOx SA
o Ironwood Pharmaceuticals Inc
o SynZyme Technologies LLC
o Boehringer Ingelheim GmbH
o Topadur Pharma AG
o Bayer AG
· Soluble Guanylate Cyclase Market , By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Soluble Guanylate Cyclase Market , By Country
o U.S. Soluble Guanylate Cyclase Market
o Canada Soluble Guanylate Cyclase Market
o Mexico Soluble Guanylate Cyclase Market
o Europe
§ Europe Soluble Guanylate Cyclase Market , By Country
o Germany Soluble Guanylate Cyclase Market
o UK Soluble Guanylate Cyclase Market
o France Soluble Guanylate Cyclase Market
o Russia Soluble Guanylate Cyclase Market
o Italy Soluble Guanylate Cyclase Market
o Rest of Europe Soluble Guanylate Cyclase Market
o Asia-Pacific
§ Asia-Pacific Soluble Guanylate Cyclase Market , By Country
o China Soluble Guanylate Cyclase Market
o Japan Soluble Guanylate Cyclase Market
o South Korea Soluble Guanylate Cyclase Market
o India Soluble Guanylate Cyclase Market
o Southeast Asia Soluble Guanylate Cyclase Market
o Rest of Asia-Pacific Soluble Guanylate Cyclase Market
o South America
§ South America Soluble Guanylate Cyclase Market
o Brazil Soluble Guanylate Cyclase Market
o Argentina Soluble Guanylate Cyclase Market
o Columbia Soluble Guanylate Cyclase Market
o Rest of South America Soluble Guanylate Cyclase Market
o Middle East and Africa
§ Middle East and Africa Soluble Guanylate Cyclase Market
o Saudi Arabia Soluble Guanylate Cyclase Market
o UAE Soluble Guanylate Cyclase Market
o Egypt Soluble Guanylate Cyclase Market
o Nigeria Soluble Guanylate Cyclase Market
o South Africa Soluble Guanylate Cyclase Market
o Rest of MEA Soluble Guanylate Cyclase Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Soluble Guanylate Cyclase Market, By Type
5.1. Introduction
5.2. Global Soluble Guanylate Cyclase Revenue and Market Share by Type (2017-2027)
5.2.1. Global Soluble Guanylate Cyclase Revenue and Revenue Share by Type (2017-2027)
5.3. BAY-1636183
5.3.1. Global BAY-1636183 Revenue and Growth Rate (2017-2027)
5.4. Hydroxyurea
5.4.1. Global Hydroxyurea Revenue and Growth Rate (2017-2027)
5.5. BI-703704
5.5.1. Global BI-703704 Revenue and Growth Rate (2017-2027)
5.6. IW-1701
5.6.1. Global IW-1701 Revenue and Growth Rate (2017-2027)
6. Soluble Guanylate Cyclase Market, By Application
6.1. Introduction
6.2. Global Soluble Guanylate Cyclase Revenue and Market Share by Application (2017-2027)
6.2.1. Global Soluble Guanylate Cyclase Revenue and Revenue Share by Application (2017-2027)
6.3. Cardiovascular
6.3.1. Global Cardiovascular Revenue and Growth Rate (2017-2027)
6.4. Metabolic Disorders
6.4.1. Global Metabolic Disorders Revenue and Growth Rate (2017-2027)
6.5. Ophthalmology
6.5.1. Global Ophthalmology Revenue and Growth Rate (2017-2027)
6.6. Gastrointestinal
6.6.1. Global Gastrointestinal Revenue and Growth Rate (2017-2027)
7. Soluble Guanylate Cyclase Market, By Region
7.1. Introduction
7.2. Global Soluble Guanylate Cyclase Revenue and Market Share by Regions
7.2.1. Global Soluble Guanylate Cyclase Revenue by Regions (2017-2027)
7.3. North America Soluble Guanylate Cyclase by Countries
7.3.1. North America Soluble Guanylate Cyclase Revenue and Growth Rate (2017-2027)
7.3.2. North America Soluble Guanylate Cyclase Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Soluble Guanylate Cyclase by Countries
7.4.1. Europe Soluble Guanylate Cyclase Revenue and Growth Rate (2017-2027)
7.4.2. Europe Soluble Guanylate Cyclase Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Soluble Guanylate Cyclase by Countries
7.5.1. Asia-Pacific Soluble Guanylate Cyclase Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Soluble Guanylate Cyclase Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Soluble Guanylate Cyclase by Countries
7.6.1. South America Soluble Guanylate Cyclase Revenue and Growth Rate (2017-2027)
7.6.2. South America Soluble Guanylate Cyclase Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Soluble Guanylate Cyclase by Countries
7.7.1. Middle East and Africa Soluble Guanylate Cyclase Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Soluble Guanylate Cyclase Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. NicOx SA
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Ironwood Pharmaceuticals Inc
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. SynZyme Technologies LLC
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Boehringer Ingelheim GmbH
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Topadur Pharma AG
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Bayer AG
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
9. Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.1. Global Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Soluble Guanylate Cyclase Market Forecast by Regions (2017-2027)
9.2.1. North America Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.2.1.1. United States Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.2.1.2. Canada Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.2.1.3. Mexico Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.2.2. Europe Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.2.2.1. Germany Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.2.2.2. France Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.2.2.3. UK Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.2.2.4. Russia Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.2.2.5. Italy Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.2.3. Asia-Pacific Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.2.3.1. China Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.2.3.2. Japan Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.2.3.3. Korea Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.2.3.4. India Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.2.4. South America Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.2.4.1. Brazil Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.2.4.2. Argentina Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.2.4.3. Columbia Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.2.4.4. Rest of South America Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.2.5. Middle East and Africa Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.2.5.3. Egypt Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.2.5.4. Nigeria Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.2.5.5. South Africa Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.2.5.6. Turkey Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Soluble Guanylate Cyclase Market Forecast (2017-2027)
9.3. Soluble Guanylate Cyclase Market Forecast by Type (2017-2027)
9.3.1. Soluble Guanylate Cyclase Forecast by Type (2017-2027)
9.3.2. Soluble Guanylate Cyclase Market Share Forecast by Type (2017-2027)
9.4. Soluble Guanylate Cyclase Market Forecast by Application (2017-2027)
9.4.1. Soluble Guanylate Cyclase Forecast by Application (2017-2027)
9.4.2. Soluble Guanylate Cyclase Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Soluble Guanylate Cyclase Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Soluble Guanylate Cyclase Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Soluble Guanylate Cyclase Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Soluble Guanylate Cyclase Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Soluble Guanylate Cyclase Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Soluble Guanylate Cyclase Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Soluble Guanylate Cyclase Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Soluble Guanylate Cyclase Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Soluble Guanylate Cyclase Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Soluble Guanylate Cyclase Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Soluble Guanylate Cyclase Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Soluble Guanylate Cyclase Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Soluble Guanylate Cyclase Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Soluble Guanylate Cyclase Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Soluble Guanylate Cyclase Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Soluble Guanylate Cyclase Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Soluble Guanylate Cyclase Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Soluble Guanylate Cyclase Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Soluble Guanylate Cyclase Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Soluble Guanylate Cyclase Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Soluble Guanylate Cyclase Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Soluble Guanylate Cyclase Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Soluble Guanylate Cyclase Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Soluble Guanylate Cyclase Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Soluble Guanylate Cyclase Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Soluble Guanylate Cyclase Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Soluble Guanylate Cyclase Revenue and Revenue Share by Type (2017-2018)
Figure Global BAY-1636183 Revenue and Growth Rate (2017-2018)
Figure Global Hydroxyurea Revenue and Growth Rate (2017-2018)
Figure Global BI-703704 Revenue and Growth Rate (2017-2018)
Figure Global IW-1701 Revenue and Growth Rate (2017-2018)
Table Global Soluble Guanylate Cyclase Revenue and Revenue Share by Application (2017-2018)
Figure Global Cardiovascular Revenue and Growth Rate (2017-2018)
Figure Global Metabolic Disorders Revenue and Growth Rate (2017-2018)
Figure Global Ophthalmology Revenue and Growth Rate (2017-2018)
Figure Global Gastrointestinal Revenue and Growth Rate (2017-2018)
Table Global Soluble Guanylate Cyclase Revenue by Regions (2017-2018)
Figure North America Soluble Guanylate Cyclase Growth Rate (2017-2018)
Figure North America Soluble Guanylate Cyclase Revenue and Growth Rate (2017-2018)
Figure North America Soluble Guanylate Cyclase by Countries (2017-2018)
Figure North America Soluble Guanylate Cyclase Revenue (Million USD) by Countries (2017-2018)
Figure United States Soluble Guanylate Cyclase Growth Rate (2017-2018)
Figure United States Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Soluble Guanylate Cyclase Growth Rate (2017-2018)
Figure Canada Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Soluble Guanylate Cyclase Growth Rate (2017-2018)
Figure Mexico Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Soluble Guanylate Cyclase Growth Rate (2017-2018)
Figure Europe Soluble Guanylate Cyclase Revenue and Growth Rate (2017-2018)
Figure Europe Soluble Guanylate Cyclase by Countries (2017-2018)
Figure Europe Soluble Guanylate Cyclase Revenue (Million USD) by Countries (2017-2018)
Figure Germany Soluble Guanylate Cyclase Growth Rate (2017-2018)
Figure Germany Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Soluble Guanylate Cyclase Growth Rate (2017-2018)
Figure France Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Soluble Guanylate Cyclase Growth Rate (2017-2018)
Figure UK Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Soluble Guanylate Cyclase Growth Rate (2017-2018)
Figure Russia Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Soluble Guanylate Cyclase Growth Rate (2017-2018)
Figure Italy Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Soluble Guanylate Cyclase Growth Rate (2017-2018)
Figure Rest of Europe Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Soluble Guanylate Cyclase Growth Rate (2017-2018)
Figure Asia-Pacific Soluble Guanylate Cyclase Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Soluble Guanylate Cyclase by Countries (2017-2018)
Figure Asia-Pacific Soluble Guanylate Cyclase Revenue (Million USD) by Countries (2017-2018)
Figure China Soluble Guanylate Cyclase Growth Rate (2017-2018)
Figure China Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Soluble Guanylate Cyclase Growth Rate (2017-2018)
Figure Japan Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Soluble Guanylate Cyclase Growth Rate (2017-2018)
Figure Korea Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Soluble Guanylate Cyclase Growth Rate (2017-2018)
Figure India Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Soluble Guanylate Cyclase Growth Rate (2017-2018)
Figure Southeast Asia Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Soluble Guanylate Cyclase Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Soluble Guanylate Cyclase Growth Rate (2017-2018)
Figure South America Soluble Guanylate Cyclase Revenue and Growth Rate (2017-2018)
Figure South America Soluble Guanylate Cyclase by Countries (2017-2018)
Figure South America Soluble Guanylate Cyclase Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Soluble Guanylate Cyclase Growth Rate (2017-2018)
Figure Brazil Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Soluble Guanylate Cyclase Growth Rate (2017-2018)
Figure Argentina Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Soluble Guanylate Cyclase Growth Rate (2017-2018)
Figure Columbia Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Soluble Guanylate Cyclase Growth Rate (2017-2018)
Figure Rest of South America Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Soluble Guanylate Cyclase Growth Rate (2017-2018)
Figure Middle East and Africa Soluble Guanylate Cyclase Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Soluble Guanylate Cyclase by Countries (2017-2018)
Figure Middle East and Africa Soluble Guanylate Cyclase Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Soluble Guanylate Cyclase Growth Rate (2017-2018)
Figure Saudi Arabia Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Soluble Guanylate Cyclase Growth Rate (2017-2018)
Figure United Arab Emirates Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Soluble Guanylate Cyclase Growth Rate (2017-2018)
Figure Egypt Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Soluble Guanylate Cyclase Growth Rate (2017-2018)
Figure Nigeria Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Soluble Guanylate Cyclase Growth Rate (2017-2018)
Figure South Africa Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Soluble Guanylate Cyclase Growth Rate (2017-2018)
Figure Turkey Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Soluble Guanylate Cyclase Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2017-2018)
Table NicOx SA Soluble Guanylate Cyclase Financial Overview
Table Ironwood Pharmaceuticals Inc Soluble Guanylate Cyclase Financial Overview
Table SynZyme Technologies LLC Soluble Guanylate Cyclase Financial Overview
Table Boehringer Ingelheim GmbH Soluble Guanylate Cyclase Financial Overview
Table Topadur Pharma AG Soluble Guanylate Cyclase Financial Overview
Table Bayer AG Soluble Guanylate Cyclase Financial Overview
Figure Global Soluble Guanylate Cyclase Revenue (Millions USD) and Growth Rate (2018-2025)
Table Soluble Guanylate Cyclase Market Forecast by Regions (2018-2025)
Figure North America Soluble Guanylate Cyclase Market Forecast (2018-2025)
Figure United States Soluble Guanylate Cyclase Market Forecast (2018-2025)
Figure Canada Soluble Guanylate Cyclase Market Forecast (2018-2025)
Figure Mexico Soluble Guanylate Cyclase Market Forecast (2018-2025)
Figure Europe Soluble Guanylate Cyclase Market Forecast (2018-2025)
Figure Germany Soluble Guanylate Cyclase Market Forecast (2018-2025)
Figure France Soluble Guanylate Cyclase Market Forecast (2018-2025)
Figure UK Soluble Guanylate Cyclase Market Forecast (2018-2025)
Figure Russia Soluble Guanylate Cyclase Market Forecast (2018-2025)
Figure Italy Soluble Guanylate Cyclase Market Forecast (2018-2025)
Figure Rest of Europe Soluble Guanylate Cyclase Market Forecast (2018-2025)
Figure Asia-Pacific Soluble Guanylate Cyclase Market Forecast (2018-2025)
Figure China Soluble Guanylate Cyclase Market Forecast (2018-2025)
Figure Japan Soluble Guanylate Cyclase Market Forecast (2018-2025)
Figure Korea Soluble Guanylate Cyclase Market Forecast (2018-2025)
Figure India Soluble Guanylate Cyclase Market Forecast (2018-2025)
Figure Southeast Asia Soluble Guanylate Cyclase Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Soluble Guanylate Cyclase Market Forecast (2018-2025)
Figure South America Soluble Guanylate Cyclase Market Forecast (2018-2025)
Figure Brazil Soluble Guanylate Cyclase Market Forecast (2018-2025)
Figure Argentina Soluble Guanylate Cyclase Market Forecast (2018-2025)
Figure Columbia Soluble Guanylate Cyclase Market Forecast (2018-2025)
Figure Rest of South America Soluble Guanylate Cyclase Market Forecast (2018-2025)
Figure Middle East and Africa Soluble Guanylate Cyclase Market Forecast (2018-2025)
Figure Saudi Arabia Soluble Guanylate Cyclase Market Forecast (2018-2025)
Figure United Arab Emirates Soluble Guanylate Cyclase Market Forecast (2018-2025)
Figure Egypt Soluble Guanylate Cyclase Market Forecast (2018-2025)
Figure Nigeria Soluble Guanylate Cyclase Market Forecast (2018-2025)
Figure South Africa Soluble Guanylate Cyclase Market Forecast (2018-2025)
Figure Turkey Soluble Guanylate Cyclase Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Soluble Guanylate Cyclase Market Forecast (2018-2025)
Figure Global Soluble Guanylate Cyclase Forecast by Type (2018-2025)
Figure Global Soluble Guanylate Cyclase Market Share Forecast by Type (2018-2025)
Figure Global Soluble Guanylate Cyclase Forecast by Type (2018-2025)
Figure Global Soluble Guanylate Cyclase Forecast by Application (2018-2025)
Figure Global Soluble Guanylate Cyclase Market Share Forecast by Application (2018-2025)
Figure Global Soluble Guanylate Cyclase Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|